Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Nicola Davis Science correspondent

New diabetes drugs do not tackle root causes of obesity, experts warn

Semaglutide (Wegovy) has been approved for use in the UK for certain groups of people with obesity
Semaglutide (Wegovy) has been approved for use in the UK for certain groups of people with obesity. Photograph: Cristian Mihaila/AP

The promise of breakthrough drugs to help people lose weight must not be used as an excuse to avoid tackling the root causes of obesity, experts have warned, as concerns grow over a scramble for the slimming jabs.

According to recent figures, the proportion of adults in England who are obese rose from 14.9% to 28% between 1993 and 2019, while NHS England data reveals that in 2019-20 there were 10,780 hospital admissions directly attributable to obesity.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.